Arunjyoti Bio Ventures Ltd

Arunjyoti Bio Ventures Other Announcement

Arunjyoti Bio Ventures Limited has changed its corporate name to Pasura Industries Limited, effective September 2, 2026.

Arunjyoti Bio Ventures Annual General Meeting

Arunjyoti Bio Ventures Ltd held its 40th Annual General Meeting on August 12, 2026, via video conference. The company disclosed proceedings of the meeting.

Arunjyoti Bio Ventures Annual General Meeting

Arunjyoti Bio Ventures Ltd. will hold its 40th Annual General Meeting on August 12, 2026, to conduct ordinary business and approve the appointment of secretarial auditors.

Arunjyoti Bio Ventures Other Announcement

Arunjyoti Bio Ventures Ltd has filed its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with SEBI regulations.

Arunjyoti Bio Ventures Management Change

Arunjyoti Bio Ventures appointed M/s. Vivek Surana & Associates as Secretarial Auditor for five years. This follows the resignation of M/s. Manoj Parakh & Associates.

Execution

60 months

Arunjyoti Bio Ventures Q1 FY27 Results: Net Profit ₹0.6 Cr, Down 70.0% YoY

Arunjyoti Bio Ventures Ltd reported revenue from operations of ₹8.2 Cr (-5.7% YoY) and net profit of ₹0.6 Cr (-70.0% YoY) for Q1 FY27.

Key figure

Net profit ₹0.6 Cr · -70.0% YoY

Arunjyoti Bio Ventures Board Meeting Date

Arunjyoti Bio Ventures Ltd will hold a Board Meeting on July 9, 2026. The agenda includes reviewing un-audited financial results for the quarter ended June 30, 2026.

Arunjyoti Bio Ventures Q4 FY26 Results: Net Loss of ₹5.4 Cr, Loss Widens

Arunjyoti Bio Ventures Ltd reported revenue from operations of ₹7.2 Cr (+35.8% YoY) and a net loss of ₹5.4 Cr for Q4 FY26.

Key figure

Net loss ₹5.4 Cr

Arunjyoti Bio Ventures Financial Results

Arunjyoti Bio Ventures reported audited FY2026 results and approved a ₹2.74 Crore write-off. The company also corrected a prior period deferred tax error.

Value

₹2.74 Cr

Arunjyoti Bio Ventures Board Meeting Date

Arunjyoti Bio Ventures postponed its May 12 board meeting to May 13, 2026. The meeting will consider audited financial results for the prior fiscal year.

Arunjyoti Bio Ventures Board Meeting Date

Arunjyoti Bio Ventures Limited has postponed its Board Meeting originally scheduled for May 8, 2026, to May 12, 2026, due to unavoidable reasons. The meeting will consider and approve audited financial results for the quarter and year ended March 31, 2026. The agenda for the meeting remains unchanged.

Arunjyoti Bio Ventures Board Meeting Date

Arunjyoti Bio Ventures Ltd has scheduled a Board of Directors meeting for May 8, 2026. The board will primarily consider and approve the audited financial results for the quarter and year ended March 31, 2026.

Arunjyoti Bio Ventures Debt & Borrowing

Arunjyoti Bio Ventures Limited has submitted its annual disclosure for FY 2025-26, confirming it does not qualify as a 'Large Corporate' under SEBI debt-raising norms. Consequently, the company has no mandatory requirement to raise incremental borrowings through debt securities.

Arunjyoti Bio Ventures Debt & Borrowing: ₹20.57 Cr

Arunjyoti Bio Ventures Ltd disclosed that it does not qualify as a 'Large Corporate' under SEBI norms for FY 2026-2027. The company reported outstanding borrowings of ₹20.57 Crore as of March 31, 2026, which is below the ₹1,000 Crore threshold required for the Large Corporate framework.

Value

₹20.57 Cr

Arunjyoti Bio Ventures Other Announcement

Chennupati Sarath Kumar sold 54,25,516 equity shares of Arunjyoti Bio Ventures Limited, representing a 2.91% stake, via the open market. This transaction reduced the seller's total holding from 7.57% to 4.66%.

Execution

13.04.2026-16.04.2026

Arunjyoti Bio Ventures Price Movement Clarification

Arunjyoti Bio Ventures Ltd (BSE: 530881) issued a clarification regarding unsolicited messages allegedly being circulated about the company's shares. The company advised investors to exercise due care and caution while dealing in its scrip. This disclosure is made under Regulation 30(11) of SEBI (LODR) Regulations, 2015.

Arunjyoti Bio Ventures Promoter Selling

Promoter Chennupati Sarath Kumar sold 60,97,684 equity shares of Arunjyoti Bio Ventures Limited (3.27% stake) via the open market between March 23 and April 10, 2026. Following this sale, the promoter's holding decreased from 10.84% to 7.57% of the company's total equity share capital.